1. Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial. Issue 11 (10th April 2022) Authors: Giné, Eva; de la Cruz, Fátima; Jiménez Ubieto, Ana; López Jimenez, Javier; Martín García-Sancho, Alejandro; Terol, M. José; González Barca, Eva; Casanova, María; de la Fuente, Adolfo; Marín-Niebla, Ana; Muntañola, Ana; González-López, Tomás José; Aymerich, Marta; Setoain, Xavier; Cortés-Romera, M... Journal: Journal of clinical oncology Issue: Volume 40:Issue 11(2022) Page Start: 1196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗